Aquestive Therapeutics Inc.

AQST | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.78

+$0.17 (+3.69%)

At close: Sep 21, 2026, 4:00 PM ET

$4.74

-$0.04 (-0.84%)

After-hours: Sep 21, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.69%

(1D)

Rating

Updated: Aug 26, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $599.73M

1D Range

4.63 4.83

52W Range

2.93 7.55

Valuation (TTM)

PE -7.35

PB -10.60

EV/EBITDA -9.14

Valuation (NTM)

Forward PE N/A

Forward PEG -3.92

Price Target $11

Cash Flow

FCF Yield -7.7%

SBC Adj. FCF Yield -9.2%

SBC Impact -20.4%

Margins

Gross Margin 67.0%

Operating Margin -97.5%

FCF Margin -85.0%

Growth (CAGR)

Revenue 3Y | 5Y 5.2% | 5.3%

Dil EPS 3Y | 5Y -26.5% | 28.0%

FCF 3Y | 5Y -26.1% | -24.0%

Returns

ROA -59.2%

ROE 243.7%

ROIC -45.3%

Financial Health

Net Cash

$47.84M

Current Ratio 7.19

Interest Coverage -3.23

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both the United States and i...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 147

IPO Date Jul 24, 2018

Website www.aquestive.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$11

Upside

+130.13%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞